Therapy Areas: Central Nervous System
9 September 2019 - - US-based Acadia Pharmaceuticals Inc.'s (NASDAQ: ACAD) Phase 3 HARMONY study, a double-blind, placebo-controlled relapse prevention trial evaluating pimavanserin for the treat...
19 August 2019 - - The US Food and Drug Administration has approved Rozlytrek(entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC), US-based Genen...
13 August 2019 - United Kingdom-based AstraZeneca's Tagrisso (osimertinib) has improved overall survival in the patients with epidermal growth factor receptor mutated non-small cell lung cancer (...
12 August 2019 - - Anglo-Dutch biopharmaceutical company AstraZeneca has received positive overall survival results from the Phase III FLAURA trial, a randomized, double-blinded, multicenter trial of ...
1 August 2019 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) and Switzerland-based Lonza (SWX: LONN) have inked a long-term manufacturing agreement for commercial production of nar...
31 July 2019 - - The US Food and Drug Administration has accepted its New Drug Application for dasotraline, a novel dopamine and norepinephrine reuptake inhibitor, for the treatment of patients with m...
Related Headlines